| Eric Thorson, MD | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Eric Thorson |
|---|---|
| Gender | Male |
| Speciality | Surgery - Surgery Of The Hand |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184640161 | NPI | - | NPPES |
| 56417 | Other | WA | L&I |
| P01256402 | Other | WA | RR MEDICARE |
| 1184640161 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00026931 (Washington) | Secondary |
| 2086S0105X | Surgery - Surgery Of The Hand | MD00026931 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eric Thorson, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: () - | Eric Thorson, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
Alzheimer's disease (AD) is an extremely complicated disease. Several proteins seem to be involved in its cause and progression. For example, the lipid-transport protein apolipoprotein E4 (apoE4) is the major genetic risk factor for AD, and apoE4 carriers account for 65% of all Alzheimer's cases, but exactly how apoE4 contributes to the disease is unclear.
Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.
› Verified 4 days ago
Daniel R Sparks, MD Surgery Medicare: Medicare Enrolled Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Christopher Stahler, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Gerald E Gibbons, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Gregory Albert Lammert, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Jeffrey T Monson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 Fax: 509-665-6065 | |
Jordy C Cox, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-662-1511 | |
Rocky Lei Browder, MD Surgery Medicare: Medicare Enrolled Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-662-1511 |